- Home
- RCKY vs ASMB Comparison
RCKY vs ASMB Comparison
Compare RCKY & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- ASMB
- Stock Information
- Founded
- RCKY 1932
- ASMB 2005
- Country
- RCKY United States
- ASMB United States
- Employees
- RCKY N/A
- ASMB N/A
- Industry
- RCKY Shoe Manufacturing
- ASMB Biotechnology: Pharmaceutical Preparations
- Sector
- RCKY Consumer Discretionary
- ASMB Health Care
- Exchange
- RCKY Nasdaq
- ASMB Nasdaq
- Market Cap
- RCKY 196.3M
- ASMB 198.6M
- IPO Year
- RCKY 1993
- ASMB 2010
- Fundamental
- Price
- RCKY $30.55
- ASMB $22.00
- Analyst Decision
- RCKY Buy
- ASMB Strong Buy
- Analyst Count
- RCKY 1
- ASMB 4
- Target Price
- RCKY $40.00
- ASMB $41.33
- AVG Volume (30 Days)
- RCKY 54.6K
- ASMB 138.4K
- Earning Date
- RCKY 10-29-2025
- ASMB 11-06-2025
- Dividend Yield
- RCKY 2.08%
- ASMB N/A
- EPS Growth
- RCKY 24.23
- ASMB N/A
- EPS
- RCKY 2.48
- ASMB N/A
- Revenue
- RCKY $462,328,000.00
- ASMB $33,247,000.00
- Revenue This Year
- RCKY $7.02
- ASMB $11.57
- Revenue Next Year
- RCKY $3.96
- ASMB N/A
- P/E Ratio
- RCKY $12.05
- ASMB N/A
- Revenue Growth
- RCKY N/A
- ASMB 54.77
- 52 Week Low
- RCKY $11.93
- ASMB $7.75
- 52 Week High
- RCKY $33.04
- ASMB $27.17
- Technical
- Relative Strength Index (RSI)
- RCKY 62.59
- ASMB 45.20
- Support Level
- RCKY $28.64
- ASMB $20.23
- Resistance Level
- RCKY $29.69
- ASMB $22.93
- Average True Range (ATR)
- RCKY 0.96
- ASMB 1.24
- MACD
- RCKY -0.10
- ASMB -0.51
- Stochastic Oscillator
- RCKY 97.09
- ASMB 32.69
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.